Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Lethal Alleles02:41

Lethal Alleles

Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Nitazoxanide reverses pulmonary vascular remodeling in pulmonary hypertension by targeting the IMPA1-RAGE signaling axis" [Toxicology and Applied Pharmacology 507 (2026) 117657].

Toxicology and applied pharmacology·2026
Same author

Time-Dependent Association Between Breast Cancer and Risk of Ischemic Stroke: A Nationwide Cohort Study.

Neurology·2026
Same author

Solamargine alleviates liver fibrosis by regulating YAP signaling in hepatic stellate cells.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences·2026
Same author

Photo-switchable supramolecular glycochips for capturing suspension tumor cells and real-time profiling of cell surface glycosylation.

The Analyst·2026
Same author

Correction: Does cultural identity catalyze behavior? A TAM-based study on museum cultural creative products consumption in China.

PloS one·2026
Same author

Disulfidptosis: A novel cell death mechanism with pathological significance and therapeutic potential in diseases.

Pharmacological reviews·2026

Related Experiment Video

Updated: May 29, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

LOX-1 and obesity.

Meiling Yan1, Jawahar L Mehta, Changping Hu

  • 1Department of Pharmacology, School of Pharmaceutical Sciences, Central South University, Changsha, China.

Cardiovascular Drugs and Therapy
|September 2, 2011
PubMed
Summary
This summary is machine-generated.

Obesity, a common disease linked to inflammation, involves Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). This review explores LOX-1

More Related Videos

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Related Experiment Videos

Last Updated: May 29, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography
13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
06:08

Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

Area of Science:

  • Cardiovascular Science
  • Metabolic Disease Research
  • Molecular Biology

Background:

  • Obesity is a prevalent lifestyle disease linked to metabolic syndrome, insulin resistance, hypertension, dyslipidemia, and chronic inflammation.
  • It contributes to atherosclerosis and cardiovascular and renal diseases.
  • Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is a receptor for oxidized low-density lipoprotein (ox-LDL).

Purpose of the Study:

  • To review the current understanding of obesity and its complications.
  • To explore the relationship between LOX-1 and obesity.
  • To highlight LOX-1's role in obesity-related conditions.

Main Methods:

  • Literature review of studies on obesity and LOX-1.
  • Analysis of LOX-1 expression and function in obesity.
  • Synthesis of current knowledge on LOX-1's involvement in obesity pathogenesis.

Main Results:

  • LOX-1 is expressed in various cells, including endothelial cells, macrophages, and adipocytes.
  • LOX-1 plays a critical role in signal transduction and binds multiple ligands.
  • Upregulation of LOX-1 is increasingly recognized as a significant factor in obesity and its associated health issues.

Conclusions:

  • LOX-1 is implicated in the development of hypertension, diabetes mellitus, and hyperlipidemia, key risk factors for atherosclerosis.
  • LOX-1 upregulation is a vital factor in obesity and its complications.
  • Further research into LOX-1 may offer insights into managing obesity and related diseases.